Larimar Therapeutics Inc. (LRMR)
Larimar Therapeutics Max Pain By Strike
LRMR trades at $4, 60.0% above the near-term max pain of $2.5 expiring Aug 15, 2025 (0 days). Expect downward pressure as dealers benefit from price declining toward max pain. Max pain is falling across expirations ($2.5-$980), signaling increased put positioning or downside protection. Key magnetic zone at 3 where 5 expirations converge. High dispersion in max pain levels suggests competing forces and potential volatility.
Larimar Therapeutics Max Pain By Expiry
Max pain for LRMR shows a downward trend from 980 to 2.5, indicating bearish sentiment or hedging activity. The 778% spread signals divergent expectations across timeframes. Levels distributed around 4. Strong magnetic level at 3 (5 expirations). Weekly expirations influence price 2-3 days before expiry; monthlies throughout their final week.
Max Pain Table
| Expiration Date | Max Pain | Max Pain vs Current Price |
|---|---|---|
| Aug 15, 2025 | 2.5 | -1.50 (-37.42%) |
| Sep 19, 2025 | 5 | 1.00 (25.16%) |
| Oct 17, 2025 | 2.5 | -1.50 (-37.42%) |
| Nov 21, 2025 | 2.5 | -1.50 (-37.42%) |
| Dec 19, 2025 | 2.5 | -1.50 (-37.42%) |
| Jan 16, 2026 | 7 | 3.00 (75.22%) |
| Feb 20, 2026 | 2.5 | -1.50 (-37.42%) |
| Dec 18, 2026 | 980 | 976.00 (24430.66%) |